European Agency Favors Votubia as Adjunct Therapy for Seizures Related to TSC
News
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis’ Votubia (everolimus) dispersible tablets as an adjunctive therapy for patients, ages 2 ... Read more